Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity
- PMID: 26745609
- PMCID: PMC5482174
- DOI: 10.1097/EDE.0000000000000437
Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity
Abstract
Background: Relative risks (RRs) for cardiovascular disease (CVD) by smoking rate exhibit a concave pattern, with RRs in low rate smokers exceeding a linear extrapolation from higher rate smokers. However, cigarettes/day does not by itself fully characterize smoking-related risks. A reexamination of the concave pattern using a comprehensive representation of smoking may enhance insights.
Methods: Data were from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort enrolled in four areas of the US in 1987-1989. Follow-up was through 2008. Analyses included 14,233 participants, 245,915 person-years, and 3,411 CVD events.
Results: The concave RRs with cigarettes/day were consistent with cigarettes/day modifying a linear RR association of pack-years with CVD (i.e., strength of the pack-years association depended on cigarettes/day, indicating that the manner of pack-years accrual impacted risk). Smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration (P < 0.01). For 50 pack-years (365,000 cigarettes), estimated RRs of CVD were 2.1 for accrual at 20 cigarettes/day and 1.6 for accrual at 50 cigarettes/day. Years since smoking cessation did not alter the diminishing strength of association with increasing cigarettes/day. Analyses that accounted for competing risks did not affect findings.
Conclusion: Pack-years remained the primary determinant of smoking-related CVD risk; however, accrual influenced RRs. For equal pack-years, smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration. This observation provides clues to better understanding the biological mechanisms, and reinforces the importance of cessation rather than smoking less to reduce CVD risk.
Figures




Similar articles
-
Greater Coronary Heart Disease Risk With Lower Intensity and Longer Duration Smoking Compared With Higher Intensity and Shorter Duration Smoking: Congruent Results Across Diverse Cohorts.Nicotine Tob Res. 2017 Jul 1;19(7):817-825. doi: 10.1093/ntr/ntw290. Nicotine Tob Res. 2017. PMID: 27941116 Free PMC article.
-
Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study.Nicotine Tob Res. 2017 Jul 1;19(7):826-835. doi: 10.1093/ntr/ntw235. Nicotine Tob Res. 2017. PMID: 27651477 Free PMC article.
-
Electronic Cigarette Prevalence and Patterns of Use in Adults with a History of Cardiovascular Disease in the United States.J Am Heart Assoc. 2018 Apr 26;7(9):e007602. doi: 10.1161/JAHA.117.007602. J Am Heart Assoc. 2018. PMID: 29700041 Free PMC article.
-
Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies.Eur J Prev Cardiol. 2019 Feb;26(3):279-288. doi: 10.1177/2047487318806658. Epub 2018 Oct 18. Eur J Prev Cardiol. 2019. PMID: 30335502
-
Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis.Nicotine Tob Res. 2021 Mar 19;23(4):635-642. doi: 10.1093/ntr/ntaa156. Nicotine Tob Res. 2021. PMID: 32803250
Cited by
-
Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H801-H827. doi: 10.1152/ajpheart.00591.2018. Epub 2019 Feb 1. Am J Physiol Heart Circ Physiol. 2019. PMID: 30707616 Free PMC article. Review.
-
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.Thorax. 2018 May;73(5):414-421. doi: 10.1136/thoraxjnl-2017-210722. Epub 2018 Jan 11. Thorax. 2018. PMID: 29326298 Free PMC article.
-
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc. 2024 Sep;21(9):1219-1237. doi: 10.1513/AnnalsATS.202406-651ST. Ann Am Thorac Soc. 2024. PMID: 39051991 Free PMC article. Review.
-
Identification of Haptoglobin as a Potential Biomarker in Young Adults with Acute Myocardial Infarction by Proteomic Analysis.Malays J Med Sci. 2020 Mar;27(2):64-76. doi: 10.21315/mjms2020.27.2.8. Epub 2020 Apr 30. Malays J Med Sci. 2020. PMID: 32788843 Free PMC article.
-
An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework.J Adv Res. 2023 Jun;48:227-257. doi: 10.1016/j.jare.2022.08.012. Epub 2022 Aug 21. J Adv Res. 2023. PMID: 35998874 Free PMC article. Review.
References
-
- Benowitz NL. Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003;46(1):91–111. - PubMed
-
- Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29. - PubMed
-
- Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis. 2003;46(1):31–38. - PubMed
-
- Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res. 2003;5(5):621–624. - PubMed
-
- Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10(4):219–230. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- Z01 CP010181/ImNIH/Intramural NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources